elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34669393-1DCDCA25-BA86-4A79-A338-1C46C528311D
Q34669393-1DCDCA25-BA86-4A79-A338-1C46C528311D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34669393-1DCDCA25-BA86-4A79-A338-1C46C528311D
Benefits of concurrent syringe exchange and substance abuse treatment participation.
P304
Q34669393-1DCDCA25-BA86-4A79-A338-1C46C528311D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34669393-1DCDCA25-BA86-4A79-A338-1C46C528311D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
36a0d4b3a3e6eb4ec75992e2c29688bc2b26dbd8
P304
265-271
http://www.w3.org/2001/XMLSchema#string